首页> 美国卫生研究院文献>BMC Endocrine Disorders >Efficacy of 99mTc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease
【2h】

Efficacy of 99mTc-DTPA SPECT/CT in diagnosing Orbitopathy in graves’ disease

机译:99mTc-DTPA SPECT / CT在诊断严重疾病眼眶病中的功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe most frequently used methods of assessing Graves’ orbithopathy (GO) include: Clinical Activity Score (CAS), ultrasonography (USG), computed tomography (CT), and magnetic resonance imaging (MRI). There exists another, slightly forgotten, imaging method: single-photon emission computed tomography (SPECT) with the use of diethylenetriaminepentaacetic acid tagged with 99mTc (99mTc-DTPA). These days it is possible to conduct a SPECT examination fused with a CT scan (SPECT/CT), which increases the diagnostic value of the investigation. The aim of this paper is to evaluate the usefulness of 99mTc-DTPA SPECT/CT in diagnosing Graves orbitopathy, as compared with other methods.
机译:背景技术最常用的评估Graves眼眶病(GO)的方法包括:临床活动评分(CAS),超声检查(USG),计算机断层扫描(CT)和磁共振成像(MRI)。还有另一种略微被遗忘的成像方法:单光子发射计算机断层扫描(SPECT),它使用标记有 99m Tc( 99m Tc-DTPA)的二亚乙基三胺五乙酸。如今,可以进行结合CT扫描(SPECT / CT)的SPECT检查,这增加了检查的诊断价值。与其他方法相比,本文旨在评估 99m Tc-DTPA SPECT / CT在诊断Graves眼眶病中的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号